Tg Therapeutics (TGTX) Times Interest Earned (2011 - 2026)
Tg Therapeutics (TGTX) posted quarterly Times Interest Earned of $4.54 for Q1 2026, up 255.71% year-over-year from $1.28 in Q1 2025, and down 63.55% quarter-over-quarter from $12.45 in Q4 2025.
Powered by 
Analysis
Tg Therapeutics (TGTX) Times Interest Earned (2011 - 2026) Analysis & Trends
Tg Therapeutics' Times Interest Earned history runs 15 years deep, the most recent figure standing at $4.54 for Q1 2026.
- In Q1 2026, Times Interest Earned rose 255.71% year-over-year to $4.54; the TTM figure through Mar 2026 stood at $5.93 (up 58.17% YoY), while the FY2025 annual figure was $1.28, up 215.48% from the prior year.
- Times Interest Earned for Q1 2026 stood at $4.54, down from $12.45 in the prior quarter.
- The five-year high for Times Interest Earned was $41.16 in Q4 2022, with the low at -$13.01 in Q1 2023.
- The 5-year median for Times Interest Earned is $0.94 (2024), against an average of $3.79.
- The sharpest annual moves came in 2023 and 2024: Times Interest Earned tumbled 421.96% in 2023, then surged 872.79% in 2024.
- Tg Therapeutics' Times Interest Earned stood at $41.16 in 2022, then tumbled by 106.27% to -$2.58 in 2023, then soared by 872.79% to $19.93 in 2024, then tumbled by 37.51% to $12.45 in 2025, then plunged by 63.55% to $4.54 in 2026.
- Business Quant data shows TGTX's Times Interest Earned at $4.54 in Q1 2026, $12.45 in Q4 2025, and $2.66 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | -21.24 |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 1.42 |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | -0.08 |
| 10 | Tg Therapeutics | 7.97 Bn | 7.29 Bn | 199.14 Mn | 1.31 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.31 |
| Mar 31, 2026 | 4.54 |
| Dec 31, 2025 | 7.73 |
| Sep 30, 2025 | 4.37 |
| Jun 30, 2025 | 5.19 |
| Mar 31, 2025 | 1.28 |
| Dec 31, 2024 | 4.24 |
| Sep 30, 2024 | 1.15 |
| Jun 30, 2024 | 2.22 |
| Mar 31, 2024 | -4.05 |
| Dec 31, 2023 | -5.14 |
| Sep 30, 2023 | 30.91 |
| Jun 30, 2023 | -12.32 |
| Mar 31, 2023 | -13.01 |
| Dec 31, 2022 | -27.09 |
| Sep 30, 2022 | -21.22 |
| Jun 30, 2022 | -12.91 |
| Mar 31, 2022 | -25.10 |
| Dec 31, 2021 | -86.14 |
| Sep 30, 2021 | -82.01 |